derived therefrom

Related by string. * deriving . Derived . Deriving . Deriv : Refuse Derived Fuel . platelet derived growth . plasma derived . human platelet derived . bone marrow derived . stem cells derived . financial ratios derived / THEREFROM : applicable exemption therefrom . EXEMPT THEREFROM . proceeds therefrom . exemption therefrom . omissions therefrom . arising therefrom . derive therefrom * *

Related by context. All words. (Click for frequent words.) 55 statementsregarding 54 areforward looking 53 Safe Harbors created 53 nothistorical facts 53 withrespect 52 Forward lookingstatements 52 associated therewith 51 ofsuch 50 forward lookinginformation 50 CAUTIONARY STATEMENT Statements 50 derived 50 statements ofhistorical fact 49 historicalfacts 49 orother 49 basedon 49 futureresults 49 Theseforward looking 49 andassumptions 49 EFTI 48 Tectura Corporation 48 BCGI Shareholders 48 looking statements.These 48 historical facts areforward 48 suchstatements 48 aresubject 48 therefrom 48 dispositions joint ventures 48 including withoutlimitation 48 yet determinable 48 futureperformance 47 â € œwill â 47 constituteforward looking 47 subjectto 47 within themeaning 47 Thesestatements 47 looking statementsâ € 47 OptiCon R4 47 name selembu 47 InterDigital differentiated technology 47 looking statementswithin 47 aEURoeforward looking 47 Suchforward looking 47 Cortelco 46 arising therefrom 46 AuGRID Corporation 46 related thereto 46 looking statements.Such 46 derivations thereof 46 reflect iSIGN Media 46 suchforward looking 46 Azedra ™ 46 thispress release 46 alemtuzumab MS 46 evaluating Questcor 46 thisrelease 46 andrelated 46 VSOE 46 arebased 46 having Punknews.org account 46 herein 46 involve risksand uncertainties 46 forwarda ^ looking 46 EHSK 46 regarding Heska 46 attributing undue 46 RAPIDGate Program contains 46 regarding GreenChek 46 PGP Acquisition 46 regardingthe 45 andmarket 45 CAUTIONARY STATEMENT Certain 45 QUALCOMM Strategic Initiatives 45 forward lookingstatements 45 thereof 45 uncertaintiesthat 45 Sangamo ZFP technology 45 revise anyforward looking 45 similarexpressions 45 physicochemical 45 reflect SpatiaLight 45 includingstatements regarding 45 VIOXX Lawsuits 45 excludes depreciation amortization 45 negatives thereof 45 currentexpectations 45 VistaPrint printed 45 requestor petitioner 45 couldcause actual results 45 theseforward looking 45 theSecurities Act 45 results ofoperations 45 SecuritiesExchange Act 45 Private Securities LitigationReform Act 45 PrivateSecurities Litigation Reform Act 45 franking credits attached 45 ADSI cautions 45 CompanyaEUR TM s 45 relating thereto 44 offuture 44 expenses associated therewith 44 SearchHelp communications 44 OR INFORMATION INVOLVE 44 involverisks 44 thePrivate Securities Litigation Reform 44 includible 44 orimplied 44 expressed orimplied 44 reflect Ronn Motor 44 pertaining thereto 44 Specifically Evolving Systems 44 differmaterially 44 nonoccurrence 44 Metalline anticipated 44 mGluR4 mGluR2 44 estimates pro formas 44 Theforward looking 44 withinthe meaning 44 attendant thereto 44 amortized ratably 44 Companys 44 reasonably determinable 44 without limitation EMRISE 44 Addex Pharmaceuticals Ltd 44 adversely affect Waste Connections 44 RDEA# RDEA# RDEA# RDEA# 44 theforward looking 44 recognized ratably 44 Nanobac Pharmaceuticals Inc. 44 ProAlgaZyme R 44 statementscontained 44 Private Securities Litigation Reform 44 DISMISSED WITH PREJUDICE 44 future TEWI actions 44 concerning AudioCodes 44 todiffer materially 44 Infor expressly disclaims 44 readily ascertainable 44 xxxiii 44 * Potentially libelous 44 unequal dispensation 44 Type Nouvelle 43 APPY believes 43 adopting SFAS #R 43 thereunder 43 Ateba Resources Inc. 43 infringed misappropriated invalid 43 Vince Sorace President 43 EcaFlo ® equipment 43 events orcircumstances 43 reasonable inferences drawn 43 developments affecting SIAF 43 accompanying condensed consolidated 43 CLX Investments 43 commercially recoverable 43 RXi Pharmaceutical Corporation 43 VIOXX Product 43 commercially mineable 43 Cautionary Statements Statements 43 affecting BEO Bancorp 43 Eligard R 43 futureevents 43 chemosaturation system 43 derive 43 reflect GuestLogix 43 EquityTradingAlert.com 43 credit carryforwards 43 withoutlimitation 43 COPL 43 Pharsight WinNonlin 43 drawn therefrom 43 safeharbor 43 Zemiva TM Trofex TM 43 SVRX 43 Candente relies upon 43 includedin 43 dispositions financings 43 derivable 43 Securities Litigation Reform Act 43 ECX CFI Futures 43 projections anticipations 43 actualresults 43 nonmaterial 43 novel ZFP TFs 43 Generx TM 43 owned Cooled ThermoTherapy 43 http:/www.nuhorizons.com 43 expressly disclaimed 43 changesin 43 reflect Ronn Motors 43 Looking Statements Statements 43 CAUTIONARY STATEMENT Estimates 43 forwardlooking statements 43 results performance orachievements 43 Biomerge 43 prepetition liabilities 43 Mimetic Ligand TM 43 ILOG SA 42 Safe Harbors provision 42 IMPORTANT DISCLOSURE You 42 maydiffer materially 42 OrCrude TM process 42 DSMA Smartstox content 42 Kitsault molybdenum 42 Statements Certain 42 thoseexpressed 42 companyaEUR TM s 42 proprietary PharmacoSurgery ™ 42 reasonably estimable 42 anyforward looking 42 u pon 42 Allscripts excludes 42 applied prospectively 42 deriving 42 reflect DTRO 42 APNB 42 relating 42 referenced herein 42 litigation uncollectible receivables 42 beidentified 42 restitutionary 42 ZFNs clinical trials 42 referable 42 Qualcomm Strategic Initiatives 42 SonoPrep device 42 Magicalia assumes 42 thatmay 42 ultimate recoverability 42 hereunder 42 commercially producible 42 awardable 42 Azedra TM Onalta TM 42 OmniComm intends 42 PGiSend 42 PLAYLOGIC assumes 42 incidental thereto 42 SHOULD BE READ 42 ZFP TFs 42 LocatePLUS Statements 42 materially adversely affect 42 unasserted 42 Avicena presently derives 42 contained inthis 42 Discovery Labs KL4 42 Supplementary Product Disclosure 42 Therapeutic Diagnostics 42 -Amos Harel Haaretz Correspondent 42 These statementsare 42 Private SecuritiesLitigation Reform Act 42 equitable indemnity 42 GVAX cancer 42 Certain statements 42 attaching thereto 42 property Detournel 42 Solazed TM 42 CytoCore Solutions System 42 PAIVIS intends 42 statements arebased 42 parties hereto 42 involve risks anduncertainties 42 PRECISE trial 42 Caliper microfluidics 42 depreciation depletion amortization 42 SUPPRELIN LA DELATESTRYL 42 TEWI actions 42 ReNvision 42 TomoTherapy judgments 42 Geomark 42 #,#,# #,#,# -DH Ellis Burks 42 Statements - 42 terms Measured Indicated 42 looking statementsare 42 EcaFlo R 41 notlimited 41 APPEAL IS DISMISSED 41 too geologically speculative 41 affecting ChinaNet 41 incorporated therein 41 http:/www.camtek.co.il 41 date hereof disclaim 41 looking statements 41 TeliaSonera AB discloses 41 update theseforward looking 41 RASP Data Security 41 Statement Statements 41 update anyforward looking 41 Microcyn Technology platform 41 InterfeRx 41 therein 41 indemnitors 41 Ethyl acetate 41 indemnification clauses 41 QSAR models 41 applies prospectively 41 mGluR2 mGluR4 mGluR5 mGluR7 41 BigString Corporation intends 41 Forwardlooking statements 41 intellectualproperty 41 Contingent Value Rights 41 Haldex discloses 41 describe CoBiz 41 nonforfeitable 41 procompetitive 41 differ materiallyfrom 41 propres 41 SynerGraft 41 TrueInformation 41 SAFE HARBOR Certain 41 CORLUX CORT # 41 Secured Loan Notes 41 ofany 41 Analyte Specific Reagent 41 NYSE SFE builds 41 Novelis intentions 41 synthetic ligand 41 Madpennystocks.com 41 EIFH 41 Nanobac Life Sciences 41 determinable 41 uncertainties materialize Shire plc 41 b Relates 41 Domilens 41 SOFTWARE PRODUCT 41 PLAYLOGIC 41 orotherwise 41 BY MAKING THESE 41 accordance therewith 41 pharmaceutically acceptable 41 forward.looking statements 41 AUCTIONEER CONSIGNOR OR 41 accretion dilution 41 forward lookingstatement 41 attached condensed consolidated 41 financialperformance 41 Underlying Entities 41 Oncolin Quarterly Reports 41 carryforwards 41 promisee 41 Copano commodity 41 uncertainties materialize Shire 41 Propipper 41 forwardlooking 41 concerning Epigenomics AG 41 Corporation NASDAQ PGIC 41 Adjusted pro forma 41 racemate 41 NewHeights Software Corporation 41 immunotherapies 2A/Furin 41 historical facts 41 LunarEye 41 reflect DOR BioPharma 41 PFICs 41 Connetics disclaims 41 risks anduncertainties 41 Private Securities Litigation ReformAct 41 Targacept cautions 41 VocalTec Communications 41 unproved resource 41 Injunctive relief 41 aEUR aEUR aEUR 41 Statements Statements 41 hereinabove 41 Georox Resources Inc. 41 seladang Malay 41 merely colorable 41 offerings visit www.balqon.com 41 MFA MBS 41 affecting Amarin 41 unconsolidated joint 41 limitedto 41 b Represents 41 IAB eContent 41 EndoTAG TM 41 PolyCides 41 GLJ Report 41 Amalgamating Corporations 41 GSI Commerce expressly disclaims 41 ChiSys 41 reflect HRTE 41 SAFE HARBOR Except 41 HMSG 41 bargain Adgate 40 Ii Key 40 actuarially determined 40 negatives thereof variations thereon 40 Toreador intends 40 § #-#.# [003] 40 Acorda Therapeutics disclaims 40 FICO disclaims 40 expressly qualifies 40 causeactual results 40 competitively procured pursuant 40 OneEx 40 theCompany 40 concerning Alnylam 40 Colo. Sess 40 ZapMedia applied 40 underlying sulfide mineralization 40 http:/www.sap.com/investor 40 Risks uncertainties 40 theirrespective owners 40 NO RETURNS 40 URL categorization 40 sublicense agreements 40 Telstra eBusiness 40 escrowed proceeds 40 Tecstar Automotive Group 40 Newtek beliefs 40 d Represents 40 BioNeutral routinely 40 #.Forward looking 40 contemplated therein 40 Nventa proprietary CoVal 40 undetected errors 40 Medarex disclaims however 40 Sepracor patents 40 PDL BioPharma logo 40 includable 40 relation thereto 40 chemoprotective 40 delivers demonstrable 40 boron chemistry 40 OR SIMILAR STATEMENTS ARE 40 mixtures thereof 40 Wider Trintech Group 40 LIFO inventory decrement 40 substantiate CytoCore expectations 40 Oral BDP 40 c Represents 40 Isis Alnylam 40 indemnitee 40 visit www.parpharm.com 40 galactomannan 40 ADSI reliance 40 SANCTURA SANCTURA XR VANTAS 40 economically producible 40 ascertainable 40 BugOil R 40 express Luminex 40 ® ConsumerReports.org 40 anticipates foresees forecasts 40 Voisey Bay royalty 40 attribution authenticity provenance 40 mergers dispositions 40 Axenohl 40 c Reflects 40 xxii 40 LifePoint LifePoint Hospitals 40 Looking Statements Certain 40 NexPrise 40 SAFE HARBOUR 40 Hiru Corporation cautions 40 PURPOSE OF SAFE HARBOR 40 d Reflects 40 thedate 40 toreflect 40 CDO financings 40 Nektar proprietary 40 relatedto 40 Private Securities Reform Act 40 xvii 40 Insmed disclaims 40 pro forma condensed consolidated 40 tortuous interference 40 Nasdaq BFRM 40 provide TransCanada securityholders 40 EGRIFTA TM 40 Banks.com s 40 AMERISTAR CASINOS INC. AND 40 Cautionary Disclosures 40 Rescula 40 TASE EVGN.TA 40 promissory fraud 40 Default Notice i 40 Enerchem 40 leveraging ATG 40 VitroTech 40 CyberDefender expectation 40 homocysteine assay 40 JM Dutton adds 40 newinformation future 40 xxvii 40 objectively verifiable 40 ATMI undertakes 40 howsoever arising 40 Excess Cash Flow 40 STRATEGIC ALTERNATIVES 40 inventories revalued 40 Vaxfectin ® 40 incur unanticipated 40 please visit www.mscsoftware.com 40 alternate payee 40 iii 40 Reconciliation Tables 40 JUVISTA 40 Charmer Charts shall 40 reviewed de novo 40 Lasertel subsidiary 40 AccessIT undertakes 40 terminable 40 Somaxon interpretation 40 ofnew 40 PLACE UNDUE IMPORTANCE ON 40 MTM Technologies disclaims 40 anduncertainties 40 harbor provisions 40 patented NanoStat TM 40 concerning iAnywhere Solutions 40 GreenHunter Energy undertakes 40 beconsidered 40 interferon beta GLP 40 inconnection 40 SEC Rule #g# 40 www.klgold.com 40 EnerCare Solutions 39 controverted 39 Act of# 39 Medarex UltiMAb 39 indications contraindications 39 Geac intentions 39 validity enforceability 39 reflect Medicago 39 Global DIGIT 39 botanically derived 39 Capitalised terms used 39 EXPECTED RESULTS MAY INCLUDE 39 Capitalised terms 39 ClickFind 39 materially overstated 39 looking statements includingbut 39 hereby retracts 39 contractual indemnity 39 adverse determinations 39 E Forex.ro accepts 39 aux actionnaires 39 Safe Harbor Forward Looking 39 Harmonic Electra 39 SuperMedia specializes 39 Filtran Microcircuits Inc. 39 β carotene 39 Although Franconia Minerals 39 ECX CFI 39 nonpecuniary 39 associatedwith 39 Syngenta ADSs nor 39 meaningof 39 Debt Settlement Agreements 39 PalWeb 39 STATEMENTS Certain 39 ddRNAi 39 CRHI 39 DPSPs 39 Rarely Salmonella 39 reflect events orcircumstances 39 FINOTEC Trading assumes 39 thereto 39 Palatin intends 39 ofthese 39 concerning Wowjoint 39 CellScan 39 Liability Lawsuits 39 ii 39 executory contracts 39 SemCanada 39 indebtedness covenant 39 arising 39 without limitation 39 visit http:/www.parpharm.com/ 39 AMO disclaims 39 VISaer 39 merchant chargebacks 39 differ materially fromthose 39 Thalomid R 39 physico chemical properties 39 miRNA expression profiles 39 b Excludes 39 EnPro consolidated 39 VeraTag assays 39 exhibits hereto 39 GigOptix disclaims any 39 Purifine enzyme 39 FSAH 39 ALDA assumes 39 XL# anticancer compounds 39 readily determinable 39 Contingent Consideration 39 viruses bacteria archaea 39 KRS #.# [003] 39 whichare 39 Optiquel ™ 39 adjusted unlevered free 39 accompanying Explanatory Memorandum 39 appraisement laws 39 Agria beliefs 39 Sepracor anticipates 39 deviates materially 39 incurs amortization 39 Sharps SP 39 TÎ ² 4 39 aEUR aEUR 39 visit http:/www.parpharm.com 39 aEURoeanticipatesaEUR aEURoedraftaEUR aEURoeeventuWainohu 39 condensed consolidated balance sheets 39 splice variants 39 Unfunded pension 39 Daytrana TM 39 IP PBX telephony 39 risksand uncertainties 39 ARE NOT INDICATIVE OF 39 Disclaimer Past performance 39 Repl. 39 § #.#-# [001] 39 synthetically manufactured 39 visit biotech.com 39 methodology artificially inflates 39 fidelity haptic systems 39 shipper ie 39 accruable 39 NOL carryforward 39 Novadaq SPY System 39 reflecting Achillion 39 unpatentable 39 THIS DOCUMENT CONTAINS CERTAIN 39 Aphthasol R 39 NRS #.# [003] 39 anti neoplastic 39 Atheros disclaims 39 Nellix 39 DSMA Smartstox 39 Act ERISA Breach 39 Second Supplementary Bidder 39 - Adjusted [012] 39 xxxii 39 strictly informational 39 e fficiency 39 conditional tenses 39 Cautionary Statements Certain 39 Settling Defendants 39 Immersion disclaims 39 release contains 39 excluding QSI 39 xiv 39 READER ADVISORY 39 andoperating 39 Altra Industrial 39 La.Civ.Code art 39 NxStage anticipates 39 -lipid nanoparticles 39 mildly dilutive 39 foregoing cautionary statements 39 Tender Offer Memorandum 39 G. biloba 39 émises 39 LogicVision disclaims 39 Escrowed Proceeds 39 3W Power 39 newproducts 39 contained herein 39 applicable 39 downloading via http:/fraport.cms-gomex.com 39 Zhaoyuan Shuangji 39 realizability 39 retroactive restatement 39 inherently unknowable 39 thedate hereof 39 xii 39 geological geophysical geochemical 39 Assumptions opinions 39 tax equivalized 39 Dropdown Predecessor 39 financialstatements 39 Idera disclaims any 39 CENVAT credit 39 NRSRO ratings 39 FAFLIC 39 pursuance thereof 39 NVIDIA GeForce GPUs 39 tables summarize 39 TO IDENTIFY SUCH FORWARD 39 incorporate proprietary Microvolt 39 Rev. Proc 39 looking statements.The 39 #.These statements 39 maycause 39 AdvanSource assumes 39 discloseable transaction 39 Legerity acquisition 39 oxandrolone USP 39 customary representations warranties 39 successfully integrate Legerity 39 affect Pennichuck Corporation 39 meanings ascribed 39 nonembryonic 39 Noront Offer 39 transactions contemplated 39 ELADUR 39 facially invalid 39 proprietary analytical pharmacogenomic 39 Technipower LLC 38 IMGRC 38 debt extinguishments 38 iv 38 SANCTURA R 38 declarants 38 operatingincome 38 unrisked reserve 38 Attached hereto 38 information Thème s 38 Duska intends 38 ratemaking principles 38 proceeds therefrom 38 colorable imitations 38 Arthur Mesher CEO 38 Covered Person 38 modifi ed 38 may diverge numerically 38 looking statements.Forward 38 geology continuity 38 furnished herewith 38 MultiCell bases 38 Entereg R 38 depreciation accretion 38 xiii 38 Colfax disclaims 38 factors APPY 38 NOL carryforwards 38 EtfsHub shall 38 Citel plc 38 GreenShift corn 38 OR INFORMATION 38 TSX VENTURE XCT 38 PAIVIS actual 38 thereby negatively impacting 38 MyoCell SDF 1 38 Sikanni 38 theSecurities 38 liquidating distributions 38 punitive incidental 38 please visit http:/www.toshiba.com/taec/ 38 similarly titled captions 38 BUFC Equity Securities 38 Whitebox Entities 38 Varvarinskoye Project 38 Zemiva TM 38 PROVISIONS OF THE PRIVATE 38 Taxability 38 Alpetro 38 Cautionary Statements section 38 Resverlogix Corp. 38 noncash impairments 38 HIMC Corporation 38 HTTD 38 presumptively invalid 38 reestimates 38 Portec undertakes 38 Goggin holed 38 Neose subsequent 38 taxability 38 regarding Anviron 38 Trofex ™ 38 antigen fusion 38 thetransaction 38 Acapodene R 38 resultsof 38 Mucotrol 38 Act Ciphergen disclaims 38 xxxi adverse tax 38 NOTICE IS FURTHER GIVEN 38 Rexahn licensees 38 Updated Feasibility Study 38 Medicis disclaims 38 NPVs 38 Proposed Arrangement 38 Long Term Incentive 38 f Represents 38 Alfacell proprietary ribonuclease 38 hereby waives 38 Neustar NGM 38 Rollover Applicants 38 includes radionuclide technetium 38 Elk Antelope 38 affecting mortality morbidity 38 BEO Bancorp. There 38 Section #E [002] 38 consents authorizations 38 telepresence videoconferencing 38 CEO WE SEEK 38 IEVM 38 GrowthWorks refers 38 ourproducts 38 Cerro Negro concession 38 ValueSetters 38 Statements contained 38 Decoding Financial 38 eTelecare assumes 38 ADAM disclaims 38 Section #HHC 38 selective agonists 38 SearchMedia cautions readers 38 Penske Automotive disclaims 38 INVESTORS SHOULD NOT 38 inferable 38 Nuinsco believes 38 Amylin disclaims 38 FAR #.#-# Instructions 38 Orbix R 38 proprietary PharmacoSurgery TM 38 meaningof Section #A 38 forfeitable 38 toupdate 38 Och Ziff Operating 38 Kunekt Corporation 38 NYSE Euronext disclaims 38 OPTTX System 38 phrases denoting 38 Visudyne R 38 geospatially enabled 38 Heidelberger Druckmaschinen Aktiengesellschaft 38 Offerors Commercial applies 38 PWS Shareholders 38 Privileged Access 38 hES 38 SASSA tender 38 PPG Industries periodic 38 See www.chdtcorp.com 38 Microwave Fiber TM 38 Convera assumes 38 Looking Statements -Dunshaughlin Co Meath 38 excludes noncash 38 Pretax unrealized gains 38 Settling Parties 38 Syntroleum Process 38 please visit http:/www.gulfresourcesinc.cn 38 thereon 38 Dyna Torque 38 ON FORWARD LOOKING 38 volumetric calculations 38 indirect incidental 38 APNB believes 38 Market Pulse.com MP 38 React NTI 38 Biogold Fuels 38 Optibase breadth 38 FxMAX 38 mutually satisfactory definitive 38 anti CD3 38 CV Therapeutics disclaims 38 Airesurf 38 ReCyte 38 http:/www.bphx.com 38 difficulties foreseeing 38 calculating distributable cash 38 incommensurable 38 Orthodyne 38 AXGJ 38 n otwithstanding 38 intentions anticipations beliefs 38 inure 38 CommVault beliefs 38 reflect PREIT 38 SYNNEX Corporation assumes 38 No. #R 38 p laintiffs 38 punctal plug 38 XFMedia beliefs 38 OraSure Technologies undertakes 38 vagazette.com 38 Kitsault molybdenum mine 38 unanticipated geological 38 Peyronie disease Frozen Shoulder 38 collaterally attack 38 Statements contained herein 38 xenograft implants 38 asymmetric catalysis 38 included Pentaerythritol tetranitrate 38 Mago ® 38 viii 38 unanticipated difficulties 38 Company website www.nyandcompany.com 38 nontestimonial 38 DIP Loan 38 thegolfchannel.com 38 MHT Amended Asset 38 Recommendation Statement 38 NII Holdings disclaims 38 Hexion Proposal 38 materially misstate 38 intercompany arrangements 38 purely historical 38 proprietary Mimetic Ligand 38 website www.nyandcompany.com 38 Rosebel royalty 38 economically recoverable reserves 38 ACS disclaims 38 TrueKnowledge Platform TM 38 Neuftec 38 #.#per diluted 38 INOVA Geophysical 38 Section #A [002] 38 cerebral somatic oximeter 38 Loudeye assumes 38 EMEA Subsidiaries 38 Normalizing adjustments 38 cause actual resultsto 38 arbitrable 38 nonappealable 38 winning DEMOletter 38 SRD deferred 38 inures 38 Verenium expressly disclaims 38 equitable apportionment 38 Enlarged Group 38 Synbiotics Corporation 38 Dobhai 38 Nortel unfunded 38 Virage Logic disclaims 38 excludes unrealized gains 38 Cognex disclaims 38 Petrolympic reasonable 38 earnings pershare 38 ISDA Master Agreement 38 noncash amortization 38 CADRI 38 b Reflects 38 Evader Inc. 38 Playlogic assumes 38 TLCVision anticipated 38 NOL utilization 38 vii Cubist ability 38 GigaMedia cautions readers 38 intents beliefs 38 Cautionary Information 38 Falconbridge Acquisition 38 Homeownership bestows 38 Graniz Loan 38 excluding nonrecurring 38 prejudicially affected 38 XP# XP# 38 receive nonforfeitable dividends 37 Hybridan LLP 37 § #A [003] 37 FEGR disclaims 37 Airvana anticipates 37 nonGAAP 37 Forward Looking StatementsThis 37 Emailwire.com ™ http:/www.emailwire.com 37 unsmiling pessimism 37 = Supplemental disclosure [001] 37 render PolyHeme obsolete 37 Zunicom Inc. 37 BioForce Nanosciences actual 37 Forward looking 37 Schefferville Properties 37 DISCLOSURE NOTICE 37 permitting timelines 37 human pluripotent stem 37 ex turpi causa 37 presold mortgages 37 indemnifiable 37 #.# subd [006] 37 Assumptions relating 37 please visit www.wpcs.com 37 Cheniere Partners 37 LML PAYMENT SYSTEMS INC. 37 justificatory 37 amortizable intangible assets 37 -worht 37 pressrelease 37 underwriting discounts commissions 37 Tarakuli 37 looking statementsaEUR describe 37 PBG undertakes 37 potential acquirors 37 BackWeb assumes 37 Solicitation Statement 37 reflecting Maximizer Software 37 preceding paragraphs 37 simpliciter 37 intercompany receivables 37 EnterpriseTenFold SOA 37 aEURoeprojectedaEUR 37 Sponsors sole discretion 37 Pixelplus assumes 37 CholeraGarde R Peru 37 Gramercy Realty Lenders 37 RAD SVT 37 materiality predictions 37 hoFH 37 Umbilical cord stem cells 37 Medigen 37 Mediaseed R 37 SilverSeek.com 37 DECISION TO INVEST 37 Proxcelan Cesium 37 ThG diploma 37 ALL STATEMENTS CONTAINED 37 non GAAP1 37 ZDP Shares 37 Conexant stockholders 37 Continuing Operations Before

Back to home page